The Prognostic Value of Early Detection of Minimal Residual Disease As Defined by Flow Cytometry and Gene Mutation Clearance for Myelodysplastic Syndrome Patients after Myeloablative Allogeneic Hematopoietic Stem-Cell Transplantation.
Frontiers in oncology（2021）
关键词
myelodysplastic syndromes (MDS),allogeneic hematopoietic stem cell transplantation (AHSCT),minimal residual disease (MRD),multiparameter flow cytometry (MFC),gene mutation clearance
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要